Floatz logo

3 assets in Mucopolysaccharidosis Type 7

Therapeutic assets addressing Mucopolysaccharidosis Type 7, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Busulfanum
Mucopolysaccharidosis Type 7
Masonic Cancer Center, University of MinnesotaP2B (57)
Cald Hr-D
Mucopolysaccharidosis Type 7
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Iduronidase, .Alpha.-L-(8-Histidine) (Human)
Mucopolysaccharidosis Type 7
University of California, San FranciscoP1CC (43)